Aceprilone

Product Description

Composition: Eperisone HCL (150mg) & Aceclofenac IP (200mg) (In Sustained Release Form)

Aceprilone Tablets represent a breakthrough dual-action formulation specifically engineered to address muscle pain, spasticity, and inflammation through complementary pharmaceutical mechanisms. The sustained-release technology ensures consistent therapeutic levels throughout the day, providing prolonged relief without the fluctuating pain cycles associated with immediate-release formulations. Eperisone HCL, a centrally-acting muscle relaxant, works by modulating muscle tone and reducing neuromuscular hyperactivity that creates painful muscle tension and rigidity. This selective action distinguishes Eperisone from traditional muscle relaxants by improving muscle blood flow and oxygen delivery while reducing painful muscle spasms without causing excessive sedation or drowsiness that interferes with daily activities. The addition of Aceclofenac IP 200mg, a potent NSAID from the propionic acid class, provides powerful anti-inflammatory and analgesic benefits that target the inflammatory component of muscle and joint pain. Together, these two pharmaceutically-active ingredients create a synergistic effect that addresses pain from multiple angles—reducing muscle tension while simultaneously controlling inflammation, making Aceprilone exceptionally effective for acute and chronic musculoskeletal conditions.

The mechanism of action makes Aceprilone particularly valuable for patients experiencing muscle-related pain that resists monotherapy treatment. Eperisone works at the spinal cord level to reduce the excessive motor neuron activity that perpetuates muscle spasms and rigidity, while simultaneously improving microcirculation within affected muscles, promoting faster healing and recovery. This dual mechanism—reducing muscle hyperactivity while improving blood flow—creates rapid pain relief that patients notice within hours of administration. Aceclofenac complements this action by inhibiting prostaglandin synthesis and reducing inflammatory mediators that amplify pain perception and trigger muscle guarding responses. Unlike some NSAIDs that merely suppress symptoms, Aceclofenac’s selective COX-2 inhibition provides targeted anti-inflammatory action while maintaining a favorable gastrointestinal safety profile. The sustained-release formulation is critical for optimal results, as it maintains therapeutic drug levels continuously, preventing the pain breakthrough that often occurs with immediate-release formulations and allowing patients to maintain consistent pain control throughout waking hours.

Aceprilone tablets are ideal for managing diverse musculoskeletal conditions where inflammation and muscle tension coexist as primary pain drivers. Patients with cervical spondylosis, lumbar spondylosis, and cervicobrachial syndrome experience significant relief as the formula addresses both the structural inflammation and the protective muscle spasms that worsen pain and limit mobility. For acute injuries—sprains, strains, and post-traumatic musculoskeletal pain—Aceprilone accelerates recovery by reducing inflammation and allowing muscles to relax, restoring normal movement patterns faster than single-agent therapies. Individuals with rheumatoid arthritis, osteoarthritis, and other inflammatory joint conditions benefit from the comprehensive anti-inflammatory action while experiencing improved muscle function around affected joints. The non-sedating profile makes Aceprilone suitable for patients who need to maintain alertness and coordination throughout the day, whether for work, driving, or other daily activities. Additionally, the sustained-release format reduces dosing frequency to twice daily, improving medication compliance and ensuring patients maintain therapeutic benefits without the burden of multiple daily doses. Whether managing acute musculoskeletal trauma or chronic inflammatory pain conditions, Aceprilone Tablets offer pharmaceutical-grade efficacy backed by established clinical evidence, making them an essential part of comprehensive pain management strategies for demanding musculoskeletal conditions.